Search

everythinglearnresearchcommunity

for

Search:↓

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testosterone may influence COVID-19 severity and outcomes.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Higher CRHR1 levels in AA patients lead to increased inflammation.